STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease
STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease
Recruiting · NCT07280585 · Registry updated 2026-07-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease | Abnormalities, Multiple, Ciliopathies, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, autosomal dominant polycystic kidney disease, cystic kidney disease, hereditary disease, kidney disorder, polycystic kidney disease, urinary system disorder | Recruiting | Phase 3 | 2026-07-28 | NCT07280585 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| German Research Foundation | 24 |
| University of Cologne | 43 |
30 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.